CAH Stock Gains on the Launch of Kendall SmartFlow Compression System
| 054561AM7 | 86.86 6.00 6.46% |
About 62% of 054561AM7's investor base is looking to short. The analysis of the overall prospects from investing in AXA EQUITABLE HLDGS suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 054561AM7's historical and current headlines, can help investors time the market. In addition, many technical investors use AXA EQUITABLE HLDGS bond news signals to limit their universe of possible portfolio assets.
054561AM7 |
Cardinal Health launches the next generation of the Kendall Compression Series, Kendall SCD SmartFlow Compression System, to aid pain relating to venous stasis.
Read at zacks.com
 |
054561AM7 Fundamental Analysis
We analyze 054561AM7's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 054561AM7 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 054561AM7 based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
AXA EQUITABLE cannot be rated in Probability Of Bankruptcy category at this point.Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
AXA EQUITABLE HLDGS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 054561AM7 bond to make a market-neutral strategy. Peer analysis of 054561AM7 could also be used in its relative valuation, which is a method of valuing 054561AM7 by comparing valuation metrics with similar companies.
Peers
054561AM7 Related Equities
| ALNT | Allient | 1.22 | ||||
| CAH | Cardinal Health | 0.16 | ||||
| AMKR | Amkor Technology | 0.99 | ||||
| ESPR | Esperion Therapeutics | 1.17 | ||||
| ARW | Arrow Electronics | 1.22 | ||||
| MBOT | Microbot Medical | 2.02 | ||||
| SCSC | ScanSource | 2.66 |
Other Information on Investing in 054561AM7 Bond
054561AM7 financial ratios help investors to determine whether 054561AM7 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 054561AM7 with respect to the benefits of owning 054561AM7 security.